Feedback / Questions
fulranumab (AMG-403) - Amgen
JNJ Pharmaceuticals: Business Review
(Johnson and Johnson Ltd)
-
May 31, 2013 -
"Fulranumab Improves Pain and Function in Osteoarthritis and Diabetic Peripheral Neuropathy"
P2 data
•
Pain
http://files.shareholder.com/downloads/JNJ/2284484687x0x666474/c035b7ba-8fd6-4bf7-832c-01a0697e2380/JNJ_Pharm_Business_Review_2013.pdf
May 31, 2013
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.